H.R. 5414
Referred to CommitteeFDA Cross-Center Collaboration Act of 2016
Introduced 6/8/2016•114th Congress•House
Latest Action
Referred to the House Committee on Energy and Commerce.
6/8/2016 • House
Summary
FDA Cross-Center Collaboration Act of 2016
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish one or more Intercenter Institutes. Each institute must coordinate activities applicable to a major disease area among the FDA centers that review products. Activities may include coordinating staff with relevant expertise, streamlining product review, and enhancing interactions with patients, sponsors, and the biomedical community.Introduced in House • 6/8/2016
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Government employee pay, benefits, personnel managementHealth promotion and preventive careMedical education
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
R[
Bill Journey
Originated in the House
Introduced
June 8, 2016
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House6/8/2016